Akari Therapeutics Plc - AKTX

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$1.657M
QoQ value delta ($000)
+$22K (+1.35%)
Implied price effect (QoQ)
-0.16%
Shares
Total shares
162,391
QoQ shares delta
+2,411 (+1.51%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (AKTX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 1 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
MMCAP International Inc. SPC 1,024 100,000 0.09%
Cresset Asset Management, LLC 210 20,561 0.0%
JANE STREET GROUP, LLC 158 15,463 0.0%
HRT FINANCIAL LP 140 13,745 0.0%
CITADEL ADVISORS LLC 102 10,000 0.0%
GAMMA Investing LLC 22 2,411 0.0%
IFP Advisors, Inc 1 181 0.0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0 7 0.0%
Truvestments Capital LLC 0 1 0.0%
SBI Securities Co., Ltd. 0 14 0.0%
Caitong International Asset Management Co., Ltd 0 8 0.0%